Source Feed: The Globe and Mail
Author: Kelly Grant
Publication Date: October 26, 2025 - 21:08
Health Canada approves drug that slows progression of Alzheimer’s disease
October 26, 2025
Health Canada has for the first time approved a disease-modifying drug for Alzheimer’s disease, a watershed moment that offers hope for patients but does not guarantee that the complex and expensive intravenous therapy will be widely available in this country.
The federal regulator on Friday granted a conditional authorization for lecanemab, an antibody drug that can slow the progression of the disease for some people with mild cognitive impairment or early-stage dementia owing to Alzheimer’s.
Unpublished Newswire
After reading a very well written article by Aedan Helmer about the financing of Lansdowne 2.0 I was left wondering why. Why is the mayor and a majority of city Councillors pushing for Lansdowne 2.0? Why doesn't the developer go to their bank and arrange financing? Read More
October 28, 2025 - 04:00 | Nicole Feriancek | Ottawa Citizen
WASHINGTON, D.C. — As temperatures drop and golden leaves cover lawns throughout Canada and the northern United States, residents are starting to turn on the heat. Earlier this year, amid President Donald Trump’s trade war, it appeared that energy tariffs might be used as a weapon, potentially driving up electricity prices for U.S. and Canadian consumers alike.
Canadian energy prices have risen moderately, largely due to inflation and infrastructure upgrades. But with autumn in full swing and winter looming, Americans are being warned that electricity prices are set to soar, and not...
October 28, 2025 - 04:00 | Tracy Moran | National Post
FORD SPENDING JUST LIKE WYNNE Read More
October 28, 2025 - 04:00 | Doug Menary, Ottawa Citizen | Ottawa Sun
Comments
Be the first to comment